This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Myrexis Reports Fiscal Year 2010 Results

 

Myrexis, Inc. Statements of Operations (In thousands, except per share amounts)  
  Three Months Ended June 30, Fiscal Year Ended June 30,
   2010 2009  2010   2009
  (unaudited) (unaudited) (audited) (audited)
Research revenue $ — $ 392 $ 90 $ 5,456
Costs and expenses:        
Research and development expense  6,935  12,914  28,222  54,611
Selling, general, and administrative expense  894  1,824  19,984  8,981
Total costs and expenses  7,829  14,738  48,206  63,592
Operating loss  (7,829)  (14,346)  (48,116)  (58,136)
Other income, net   22  —    1,165  — 
Net loss $ (7,807) $ (14,346) $  (46,951) $ (58,136)
Loss per basic and diluted share $ (0.31) $ (0.60) 1 $ (1.91) $ (2.43) 1
Weighted-average shares used to compute net loss per basic and diluted share  24,983  23,974 2  24,545  23,974 2
(1) Pro forma loss per basic and diluted share for fiscal year ended June 30, 2009.
(2) Pro forma shares used to compute net loss per basic and diluted share for year ended June 30, 2009.  
Myrexis, Inc. Balance Sheets (Audited) June 30, 2010 and 2009 (In thousands, except per share amounts)  
  2010 2009
Assets    
Current assets:    
Cash and cash equivalents $ 35,911 $ 128,372
Marketable investment securities  102,965  40,728
Prepaid expenses and other assets  453  240
Total current assets  139,329  169,340
Equipment and leasehold improvements:    
Equipment  6,035  5,338
Leasehold improvements  1,160  — 
   7,195  5,338
Less accumulated depreciation  1,199  — 
Net equipment and leasehold improvements  5,996  5,338
Long-term marketable investment securities  8,577  18,905
Other assets  206  94
Total assets  $ 154,108 $ 193,677
     
Liabilities and Stockholders' Equity    
Current liabilities:    
Accounts payable $ 1,927 $ — 
Accrued liabilities  2,323  4,576
Total current liabilities  4,250  4,576
     
Commitments and contingencies    
Stockholders' equity:    
Preferred stock, $0.01 par value, authorized 5,000 shares; no shares issued and outstanding  —   — 
Common stock, $0.01 par value, authorized 60,000 shares; issued and outstanding 25,214 shares at June 30, 2010; issued and outstanding 23,974 shares at June 30, 2009  252  240
Additional paid-in capital  196,532 188,400
Accumulated other comprehensive income  25  461
Accumulated deficit  (46,951)   — 
Total stockholders' equity  149,858  189,101
Total liabilities and stockholders' equity $ 154,108 $ 193,677
     
CONTACT:  Myrexis, Inc.
          Patrick M. Burke, Ph.D., V.P., Corporate and 
           Business Development
          801-214-7822
          investor.relations@myrexis.com

          The Ruth Group
          Sara Pellegrino (investors)
            (646) 536-7002
            spellegrino@theruthgroup.com
          Jason Rando (media)
            (646) 536-7025
            jrando@theruthgroup.com

Company Logo

8 of 8

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 18,030.21 +6.04 0.03%
S&P 500 2,081.88 -0.29 -0.01%
NASDAQ 4,773.4720 +8.0480 0.17%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs